Version 2.36 of HDC Discover was rolled out to production on January 23rd, 2024.  Please do not hesitate to contact our support email should you have any questions or comments about any of these changes.

What’s New? 

  • We are introducing two new chronic disease prevalence measures listed below for all EMRs:
Measure  MOIS  OSCAR  Profile  Med Access  Med Access – Legacy  Wolf 
Chronic disease prevalence – One or more  NEW  NEW  NEW  NEW  NEW  NEW 
Chronic disease prevalence – Two or more  NEW  NEW  NEW  NEW  NEW  NEW 


  • Updates have been applied to this measure name and description for increased accuracy: 
Measure  New Measure Name  New Measure Description 
Heart failure patients prescribed with ACE inhibitor or ARB in the past year  Heart failure patients prescribed a RAAS inhibitor in the past year  The percentage of active patients with Heart Failure (HF) (based on the problem list) that have had a coded prescription for a Renin-angiotensin-aldosterone system (RAAS) inhibitor (including ACE Inhibitors and Angiotensin II antagonists) in the past year recorded in the EMR. 
  • “Hypertension” and “Mood Disorder concepts 

Following user feedback, we have refined our concepts related to “Hypertension” and “Mood Disorder” to enhance precision. Consequently, users of MOIS and Med Access may observe a decrease in the reported prevalence of Hypertension and Mood Disorder in their practice. 

  • Medication Prescribing Measures

We have improved our concepts related to Medication Prescribing measures to enhance precision. Consequently, users may observe a change in their Medication Prescribing measures.